1. Home
  2. XOMA vs AWP Comparison

XOMA vs AWP Comparison

Compare XOMA & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • AWP
  • Stock Information
  • Founded
  • XOMA 1981
  • AWP 2007
  • Country
  • XOMA United States
  • AWP United States
  • Employees
  • XOMA N/A
  • AWP N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • AWP Trusts Except Educational Religious and Charitable
  • Sector
  • XOMA Health Care
  • AWP Finance
  • Exchange
  • XOMA Nasdaq
  • AWP Nasdaq
  • Market Cap
  • XOMA 330.2M
  • AWP 346.7M
  • IPO Year
  • XOMA N/A
  • AWP N/A
  • Fundamental
  • Price
  • XOMA $32.47
  • AWP $3.99
  • Analyst Decision
  • XOMA Strong Buy
  • AWP
  • Analyst Count
  • XOMA 2
  • AWP 0
  • Target Price
  • XOMA $69.50
  • AWP N/A
  • AVG Volume (30 Days)
  • XOMA 57.0K
  • AWP 331.5K
  • Earning Date
  • XOMA 08-13-2025
  • AWP 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • AWP 12.48%
  • EPS Growth
  • XOMA N/A
  • AWP N/A
  • EPS
  • XOMA N/A
  • AWP N/A
  • Revenue
  • XOMA $44,952,000.00
  • AWP N/A
  • Revenue This Year
  • XOMA $82.30
  • AWP N/A
  • Revenue Next Year
  • XOMA $12.59
  • AWP N/A
  • P/E Ratio
  • XOMA N/A
  • AWP N/A
  • Revenue Growth
  • XOMA 194.98
  • AWP N/A
  • 52 Week Low
  • XOMA $18.35
  • AWP $3.06
  • 52 Week High
  • XOMA $35.23
  • AWP $4.20
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 61.79
  • AWP 63.22
  • Support Level
  • XOMA $32.60
  • AWP $3.95
  • Resistance Level
  • XOMA $34.60
  • AWP $4.01
  • Average True Range (ATR)
  • XOMA 1.82
  • AWP 0.04
  • MACD
  • XOMA 0.09
  • AWP 0.01
  • Stochastic Oscillator
  • XOMA 66.75
  • AWP 85.71

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About AWP abrdn Global Premier Properties Fund of Beneficial Interest

Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.

Share on Social Networks: